Senior insider sale
Chief Operating Officer at X4 PHARMACEUTICALS, INC — senior position signals high conviction
$56.9K
70.34K shares
What this filing means
DIBIASE MARY plans to sell 70.34K shares of X4 PHARMACEUTICALS, INC valued at approximately $56.9K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 11/1/2023ACC: 0001973141-23-000268
Officer· Chief Operating Officer
Since Sep 2021
70.34K
Shares to sell
$56.9K
Approx. market value
67.69K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Stock Award
N/A
11/1/2023
67.69KTotal acquired67.69K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
11/1/2023 | Stock Award N/A | 67.69K | — |
| Total | 67.69K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
2.64K
Market value
$3.3K
9/8/2023
Planned — Approximate Date
NASDAQPlanned
Units to sell
67.69K
Market value
$53.6K
11/1/2023
Total
Units
70.34K
Value
$56.9K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
9/8/2023 | 2.64K | $3.3K | — | Completed |
| Planned — Approximate Date | ||||
11/1/2023 | 67.69K | $53.6K | NASDAQ | Planned |
| Total | 70.34K | $56.9K | ||